Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;13(3):202-210.
doi: 10.2174/0122115366286360240625095932.

Evaluation of Fluctuations of BRAF Gene Expression and its Polymorphism at rs1267623 in Colorectal Cancer

Seyedeh Elham Norollahi  1 , Kosar Babaei  2 , Sogand Vahidi  3 , Seyed Javad Hosseini Motaz  4 , Mahmoud Kalani Tarbeghan  4 , Mostafa Khaleghipour  2 , Elaheh Asghari Gharakhyli  5 , Seyed Reza Mirhafez  2 , Ali Akbar Samadani  2   6
Affiliations

Evaluation of Fluctuations of BRAF Gene Expression and its Polymorphism at rs1267623 in Colorectal Cancer

Seyedeh Elham Norollahi et al. Microrna. 2024.

Abstract

Background: Molecular markers in Colorectal Cancer (CRC) are needed for more accurate classification and personalized treatment. In this way, we investigated the effects of the BRAF gene on clinical outcomes of its expression fluctuations and its polymorphism at rs1267623 in CRC.

Methods: In this study, 36.36 percent of patients with CRC were women, and 63.63 percent were men. After the pathology department confirmed the tumor of the samples, the stage and grade of the tumor were determined according to the TNM system. Real-time PCR was used to check the expression of the BRAF gene in tumor and non-tumor tissues, and its polymorphism in rs1267623 was also checked using the Tetra-ARMs PCR technique.

Results: The expression of BRAF in tumor tissues was significantly higher than in non-tumoral tissues (P = 0.001), indicating an upregulation of BRAF gene expression in tumoral tissues. The user's text is empty. Furthermore, there was a significant correlation between BRAF expression and tumor stage (P = 0.001), as well as tumor grade (P = 0.003). However, no significant link was found between lymph node metastasis and distant metastasis of BRAF gene expression (P = 0.3). Additionally, no mutation was detected in the investigation of rs1267623 polymorphism.

Conclusion: The BRAF gene was upregulated in tumoral tissues. Remarkably, no mutation was found in the rs1267623 polymorphism. As a result, this gene can be used as a biomarker in the diagnosis and treatment of CRC.

Keywords: BRAF gene expression; Colorectal cancer; biomarker; diagnosis.; mutation; polymorphism.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Zhang J.; Lai W.; Li Q.; A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models. Biochem Biophys Res Commun 2017,491(2),469-477 - DOI - PubMed
    1. Rassy E.; Parent P.; Lefort F.; Boussios S.; Baciarello G.; Pavlidis N.; New rising entities in cancer of unknown primary: Is there a real therapeutic benefit? Crit Rev Oncol Hematol 2020,147,102882 - DOI - PubMed
    1. Hui D.; Kim S.H.; Roquemore J.; Dev R.; Chisholm G.; Bruera E.; Impact of timing and setting of palliative care referral on quality of end‐of‐life care in cancer patients. Cancer 2014,120(11),1743-1749 - DOI - PubMed
    1. Atlas S.J.; Zai A.H.; Ashburner J.M.; Non-visit-based cancer screening using a novel population management system. J Am Board Fam Med 2014,27(4),474-485 - DOI - PubMed
    1. Chen J.; Guo F.; Shi X.; BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients. BMC Cancer 2014,14(1),802 - DOI - PubMed